Creative Planning’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Buy
+10,913
New +$255K ﹤0.01% 3541
2025
Q1
Sell
-7,925
Closed -$206K 3497
2024
Q4
$206K Buy
+7,925
New +$197K ﹤0.01% 2955
2021
Q4
Sell
-5,000
Closed -$212K 2098
2021
Q3
$212K Hold
5,000
﹤0.01% 1826
2021
Q2
$223K Sell
5,000
-1,300
-21% -$45.8K ﹤0.01% 1744
2021
Q1
$227K Buy
6,300
+100
+2% +$3.95K ﹤0.01% 1993
2020
Q4
$247K Buy
+6,200
New +$211K ﹤0.01% 1747
2017
Q3
Sell
-143
Closed 2096
2017
Q2
$0 Hold
143
﹤0.01% 4621
2017
Q1
$0 Hold
143
﹤0.01% 4656
2016
Q4
$0 Hold
143
﹤0.01% 4620
2016
Q3
$0 Hold
143
﹤0.01% 4569
2016
Q2
$0 Hold
143
﹤0.01% 4355
2016
Q1
$0 Hold
143
﹤0.01% 4333
2015
Q4
$0 Hold
143
﹤0.01% 4410
2015
Q3
$0 Buy
+143
New +$312 ﹤0.01% 4293
2015
Q2
Sell
-143
Closed 1315
2015
Q1
$0 Hold
143
﹤0.01% 4214
2014
Q4
$0 Hold
143
﹤0.01% 4155
2014
Q3
$0 Hold
143
﹤0.01% 3992
2014
Q2
$0 Buy
+143
New +$386 ﹤0.01% 3780

Other funds holding BLFS

Creative Planning's BLFS Position: Q2 2026 in Review

Creative Planning opened a new position in BioLife Solutions (BLFS) in Q2 2026: 10,913 shares worth $308K. The stake represents ﹤0.01% of the portfolio and ranks #3541 among its holdings. This is a return to the name: Creative Planning previously reported a position in BLFS as recently as Q4 2024.

Creative Planning first reported a position in BLFS in Q2 2014 and has held it in 18 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Creative Planning held 10,913 shares of BioLife Solutions worth $308K as of Q2 2026.
  • BioLife Solutions was a new Creative Planning position in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3541 holding.
  • Creative Planning first reported a position in BioLife Solutions in Q2 2014 and has held it in 18 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.